{"id":725472,"date":"2023-01-24T16:13:15","date_gmt":"2023-01-24T21:13:15","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/exelixis-to-release-fourth-quarter-and-full-year-2022-financial-results-on-tuesday-february-7-2023\/"},"modified":"2023-01-24T16:13:15","modified_gmt":"2023-01-24T21:13:15","slug":"exelixis-to-release-fourth-quarter-and-full-year-2022-financial-results-on-tuesday-february-7-2023","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/exelixis-to-release-fourth-quarter-and-full-year-2022-financial-results-on-tuesday-february-7-2023\/","title":{"rendered":"Exelixis to Release Fourth Quarter and Full Year 2022 Financial Results on Tuesday, February 7, 2023"},"content":{"rendered":"<p>        <!--.bwalignc { text-align: center; list-style-position: inside }body {font:normal small Arial,Helvetica,sans-serif;color:#000;background-color:#fff;padding:24px;margin:0;} a img {border:0;} h3 {font-size:medium;color:#000;margin:0 0 1em 0; text-align:center;}-->  <\/p>\n<p class=\"bwalignc\"><b>Exelixis to Release Fourth Quarter and Full Year 2022 Financial Results on Tuesday, February 7, 2023<\/b><\/p>\n<p class=\"bwalignc\"><i>\u2013<\/i><i> Conference Call and Webcast to Follow at 5:<\/i><i>00 p.m. ET \/ 2:00 p.m. PT \u2013<\/i><\/p>\n<p>ALAMEDA, Calif.&#8211;(<a href=\"http:\/\/www.businesswire.com\">BUSINESS WIRE<\/a>)&#8211;<a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.exelixis.com&amp;esheet=53290287&amp;newsitemid=20230124006010&amp;lan=en-US&amp;anchor=Exelixis%2C+Inc.&amp;index=1&amp;md5=e7f24bf7572c7dfa813ba603ca4d8d31\">Exelixis, Inc.<\/a> (Nasdaq: EXEL) announced today that its fourth quarter and full year 2022 financial results will be released on Tuesday, February 7, 2023 after the markets close. At 5:00 p.m. ET \/ 2:00 p.m. PT, Exelixis management will host a conference call and webcast to discuss the results and provide a general business update. Access to the event is available via the Internet from the company\u2019s website.\n<\/p>\n<p>\nTo access the webcast link, log onto <a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.exelixis.com&amp;esheet=53290287&amp;newsitemid=20230124006010&amp;lan=en-US&amp;anchor=www.exelixis.com&amp;index=2&amp;md5=82469b954e39921bff4e134e7b0da6a1\">www.exelixis.com<\/a> and proceed to the News &amp; Events \/ Event Calendar page under the Investors &amp; Media heading. Please connect to the company\u2019s website at least 15 minutes prior to the conference call to ensure adequate time for any software download that may be required to listen to the webcast. Alternatively, please call 888-338-9509 (domestic) or 412-902-4281 (international) and ask to be joined into the Exelixis conference call to participate by phone.\n<\/p>\n<p>\nA telephone replay will be available until 8:00 p.m. ET on February 9, 2023. Access numbers for the telephone replay are: 877-344-7529 (domestic) and 412-317-0088 (international); the passcode is 7374267. A webcast replay will also be archived on <a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.exelixis.com&amp;esheet=53290287&amp;newsitemid=20230124006010&amp;lan=en-US&amp;anchor=www.exelixis.com&amp;index=3&amp;md5=56c87ee74ea0cfe261891c171858c6e7\">www.exelixis.com<\/a> for one year.\n<\/p>\n<p><b>About Exelixis<\/b><\/p>\n<p>\nExelixis is a globally ambitious oncology company innovating next-generation medicines and regimens at the forefront of cancer care. Powered by bi-coastal centers of discovery and development excellence, we are rapidly evolving our product portfolio to target an expanding range of tumor types and indications with our clinically differentiated pipeline of small molecules, antibody drug conjugates and other biotherapeutics. This comprehensive approach harnesses decades of robust investment in our science and partnerships to advance our investigational programs and extend the impact of our flagship commercial product, CABOMETYX<sup>\u00ae<\/sup> (cabozantinib). Exelixis is driven by a bold scientific pursuit to create transformational treatments that give more patients hope for the future. For information about the company and its mission to help cancer patients recover stronger and live longer, visit <a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.exelixis.com%2F&amp;esheet=53290287&amp;newsitemid=20230124006010&amp;lan=en-US&amp;anchor=www.exelixis.com&amp;index=4&amp;md5=ff0f1e1213a90b24b081cba4e057ff68\">www.exelixis.com<\/a>, follow <a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Ftwitter.com%2FExelixisInc&amp;esheet=53290287&amp;newsitemid=20230124006010&amp;lan=en-US&amp;anchor=%40ExelixisInc&amp;index=5&amp;md5=e372078dea92af477dd2176169f12171\">@ExelixisInc<\/a> on Twitter, like <a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.facebook.com%2FExelixisInc%2F&amp;esheet=53290287&amp;newsitemid=20230124006010&amp;lan=en-US&amp;anchor=Exelixis%2C+Inc.&amp;index=6&amp;md5=aa099cbbf252dbeff2cc5b486ea40d23\">Exelixis, Inc.<\/a> on Facebook and follow <a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.linkedin.com%2Fcompany%2Fexelixis%2F&amp;esheet=53290287&amp;newsitemid=20230124006010&amp;lan=en-US&amp;anchor=Exelixis&amp;index=7&amp;md5=93bd3ddee7a0c9970aa72e4ff3cb5208\">Exelixis<\/a> on LinkedIn.\n<\/p>\n<p class=\"bwalignc\"><i>Exelixis, the Exelixis logo and CABOMETYX are registered U.S. trademarks.<\/i><\/p>\n<p><img decoding=\"async\" alt=\"\" src=\"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20230124006010r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\" style=\"width:0;height:0\" \/><span class=\"bwct31415\" \/><\/p>\n<p id=\"mmgallerylink\"><span id=\"mmgallerylink-phrase\">View source version on businesswire.com: <\/span><span id=\"mmgallerylink-link\"><a href=\"https:\/\/www.businesswire.com\/news\/home\/20230124006010\/en\/\" rel=\"nofollow\">https:\/\/www.businesswire.com\/news\/home\/20230124006010\/en\/<\/a><\/span><\/p>\n<p><b>Investors Contact:<br \/>\n<\/b><br \/><i>Susan Hubbard<br \/>\n<\/i><br \/><i>Executive Vice President,<br \/>\n<\/i><br \/><i>Public Affairs &amp; Investor Relations<br \/>\n<\/i><br \/><i>Exelixis, Inc.<br \/>\n<\/i><br \/><i>650-837-8194<br \/>\n<\/i><br \/><i><a rel=\"nofollow\" href=\"mailto:shubbard@exelixis.com\">shubbard@exelixis.com<br \/>\n<\/a><br \/><\/i><br \/><b>Media Contact:<br \/>\n<\/b><br \/><i>Hal Mackins<br \/>\n<\/i><br \/><i>For Exelixis, Inc.<br \/>\n<\/i><br \/><i>415-994-0040<br \/>\n<\/i><br \/><i><a rel=\"nofollow\" href=\"mailto:hal@torchcommunications.com\">hal@torchcommunications.com<\/a><\/i><\/p>\n<p><b>KEYWORDS:<\/b> California United States North America<\/p>\n<p><b>INDUSTRY KEYWORDS:<\/b> Biotechnology Health Genetics Pharmaceutical Oncology<\/p>\n<p><b>MEDIA:<\/b><\/p>\n<table cellpadding=\"3\" cellspacing=\"3\">\n<tr>\n<td><font face=\"Arial\" size=\"2\"><b>Logo<\/b><\/font><\/td>\n<\/tr>\n<tr>\n<td><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20230124006010\/en\/1679909\/3\/Exelixis_Logo_RGB_2023.jpg\" alt=\"Logo\" \/><\/td>\n<\/tr>\n<tr>\n<td><font face=\"Arial\" size=\"2\"><\/font><\/td>\n<\/tr>\n<\/table>\n","protected":false},"excerpt":{"rendered":"<p>Exelixis to Release Fourth Quarter and Full Year 2022 Financial Results on Tuesday, February 7, 2023 \u2013 Conference Call and Webcast to Follow at 5:00 p.m. ET \/ 2:00 p.m. PT \u2013 ALAMEDA, Calif.&#8211;(BUSINESS WIRE)&#8211;Exelixis, Inc. (Nasdaq: EXEL) announced today that its fourth quarter and full year 2022 financial results will be released on Tuesday, February 7, 2023 after the markets close. At 5:00 p.m. ET \/ 2:00 p.m. PT, Exelixis management will host a conference call and webcast to discuss the results and provide a general business update. Access to the event is available via the Internet from the company\u2019s website. To access the webcast link, log onto www.exelixis.com and proceed to the News &amp; Events \/ Event Calendar &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/exelixis-to-release-fourth-quarter-and-full-year-2022-financial-results-on-tuesday-february-7-2023\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Exelixis to Release Fourth Quarter and Full Year 2022 Financial Results on Tuesday, February 7, 2023&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-725472","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Exelixis to Release Fourth Quarter and Full Year 2022 Financial Results on Tuesday, February 7, 2023 - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/exelixis-to-release-fourth-quarter-and-full-year-2022-financial-results-on-tuesday-february-7-2023\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Exelixis to Release Fourth Quarter and Full Year 2022 Financial Results on Tuesday, February 7, 2023 - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"Exelixis to Release Fourth Quarter and Full Year 2022 Financial Results on Tuesday, February 7, 2023 \u2013 Conference Call and Webcast to Follow at 5:00 p.m. ET \/ 2:00 p.m. PT \u2013 ALAMEDA, Calif.&#8211;(BUSINESS WIRE)&#8211;Exelixis, Inc. (Nasdaq: EXEL) announced today that its fourth quarter and full year 2022 financial results will be released on Tuesday, February 7, 2023 after the markets close. At 5:00 p.m. ET \/ 2:00 p.m. PT, Exelixis management will host a conference call and webcast to discuss the results and provide a general business update. Access to the event is available via the Internet from the company\u2019s website. To access the webcast link, log onto www.exelixis.com and proceed to the News &amp; Events \/ Event Calendar &hellip; Continue reading &quot;Exelixis to Release Fourth Quarter and Full Year 2022 Financial Results on Tuesday, February 7, 2023&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/exelixis-to-release-fourth-quarter-and-full-year-2022-financial-results-on-tuesday-february-7-2023\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2023-01-24T21:13:15+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20230124006010r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/exelixis-to-release-fourth-quarter-and-full-year-2022-financial-results-on-tuesday-february-7-2023\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/exelixis-to-release-fourth-quarter-and-full-year-2022-financial-results-on-tuesday-february-7-2023\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Exelixis to Release Fourth Quarter and Full Year 2022 Financial Results on Tuesday, February 7, 2023\",\"datePublished\":\"2023-01-24T21:13:15+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/exelixis-to-release-fourth-quarter-and-full-year-2022-financial-results-on-tuesday-february-7-2023\\\/\"},\"wordCount\":448,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/exelixis-to-release-fourth-quarter-and-full-year-2022-financial-results-on-tuesday-february-7-2023\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&amp;sty=20230124006010r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/exelixis-to-release-fourth-quarter-and-full-year-2022-financial-results-on-tuesday-february-7-2023\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/exelixis-to-release-fourth-quarter-and-full-year-2022-financial-results-on-tuesday-february-7-2023\\\/\",\"name\":\"Exelixis to Release Fourth Quarter and Full Year 2022 Financial Results on Tuesday, February 7, 2023 - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/exelixis-to-release-fourth-quarter-and-full-year-2022-financial-results-on-tuesday-february-7-2023\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/exelixis-to-release-fourth-quarter-and-full-year-2022-financial-results-on-tuesday-february-7-2023\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&amp;sty=20230124006010r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\",\"datePublished\":\"2023-01-24T21:13:15+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/exelixis-to-release-fourth-quarter-and-full-year-2022-financial-results-on-tuesday-february-7-2023\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/exelixis-to-release-fourth-quarter-and-full-year-2022-financial-results-on-tuesday-february-7-2023\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/exelixis-to-release-fourth-quarter-and-full-year-2022-financial-results-on-tuesday-february-7-2023\\\/#primaryimage\",\"url\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&amp;sty=20230124006010r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\",\"contentUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&amp;sty=20230124006010r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/exelixis-to-release-fourth-quarter-and-full-year-2022-financial-results-on-tuesday-february-7-2023\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Exelixis to Release Fourth Quarter and Full Year 2022 Financial Results on Tuesday, February 7, 2023\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Exelixis to Release Fourth Quarter and Full Year 2022 Financial Results on Tuesday, February 7, 2023 - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/exelixis-to-release-fourth-quarter-and-full-year-2022-financial-results-on-tuesday-february-7-2023\/","og_locale":"en_US","og_type":"article","og_title":"Exelixis to Release Fourth Quarter and Full Year 2022 Financial Results on Tuesday, February 7, 2023 - Market Newsdesk","og_description":"Exelixis to Release Fourth Quarter and Full Year 2022 Financial Results on Tuesday, February 7, 2023 \u2013 Conference Call and Webcast to Follow at 5:00 p.m. ET \/ 2:00 p.m. PT \u2013 ALAMEDA, Calif.&#8211;(BUSINESS WIRE)&#8211;Exelixis, Inc. (Nasdaq: EXEL) announced today that its fourth quarter and full year 2022 financial results will be released on Tuesday, February 7, 2023 after the markets close. At 5:00 p.m. ET \/ 2:00 p.m. PT, Exelixis management will host a conference call and webcast to discuss the results and provide a general business update. Access to the event is available via the Internet from the company\u2019s website. To access the webcast link, log onto www.exelixis.com and proceed to the News &amp; Events \/ Event Calendar &hellip; Continue reading \"Exelixis to Release Fourth Quarter and Full Year 2022 Financial Results on Tuesday, February 7, 2023\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/exelixis-to-release-fourth-quarter-and-full-year-2022-financial-results-on-tuesday-february-7-2023\/","og_site_name":"Market Newsdesk","article_published_time":"2023-01-24T21:13:15+00:00","og_image":[{"url":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20230124006010r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/exelixis-to-release-fourth-quarter-and-full-year-2022-financial-results-on-tuesday-february-7-2023\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/exelixis-to-release-fourth-quarter-and-full-year-2022-financial-results-on-tuesday-february-7-2023\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Exelixis to Release Fourth Quarter and Full Year 2022 Financial Results on Tuesday, February 7, 2023","datePublished":"2023-01-24T21:13:15+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/exelixis-to-release-fourth-quarter-and-full-year-2022-financial-results-on-tuesday-february-7-2023\/"},"wordCount":448,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/exelixis-to-release-fourth-quarter-and-full-year-2022-financial-results-on-tuesday-february-7-2023\/#primaryimage"},"thumbnailUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20230124006010r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/exelixis-to-release-fourth-quarter-and-full-year-2022-financial-results-on-tuesday-february-7-2023\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/exelixis-to-release-fourth-quarter-and-full-year-2022-financial-results-on-tuesday-february-7-2023\/","name":"Exelixis to Release Fourth Quarter and Full Year 2022 Financial Results on Tuesday, February 7, 2023 - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/exelixis-to-release-fourth-quarter-and-full-year-2022-financial-results-on-tuesday-february-7-2023\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/exelixis-to-release-fourth-quarter-and-full-year-2022-financial-results-on-tuesday-february-7-2023\/#primaryimage"},"thumbnailUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20230124006010r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en","datePublished":"2023-01-24T21:13:15+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/exelixis-to-release-fourth-quarter-and-full-year-2022-financial-results-on-tuesday-february-7-2023\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/exelixis-to-release-fourth-quarter-and-full-year-2022-financial-results-on-tuesday-february-7-2023\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/exelixis-to-release-fourth-quarter-and-full-year-2022-financial-results-on-tuesday-february-7-2023\/#primaryimage","url":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20230124006010r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en","contentUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20230124006010r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en"},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/exelixis-to-release-fourth-quarter-and-full-year-2022-financial-results-on-tuesday-february-7-2023\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Exelixis to Release Fourth Quarter and Full Year 2022 Financial Results on Tuesday, February 7, 2023"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/725472","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=725472"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/725472\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=725472"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=725472"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=725472"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}